Literature DB >> 23567086

Decoding cell death signals in liver inflammation.

Catherine Brenner1, Lorenzo Galluzzi, Oliver Kepp, Guido Kroemer.   

Abstract

Inflammation can be either beneficial or detrimental to the liver, depending on multiple factors. Mild (i.e., limited in intensity and destined to resolve) inflammatory responses have indeed been shown to exert consistent hepatoprotective effects, contributing to tissue repair and promoting the re-establishment of homeostasis. Conversely, excessive (i.e., disproportionate in intensity and permanent) inflammation may induce a massive loss of hepatocytes and hence exacerbate the severity of various hepatic conditions, including ischemia-reperfusion injury, systemic metabolic alterations (e.g., obesity, diabetes, non-alcoholic fatty liver disorders), alcoholic hepatitis, intoxication by xenobiotics and infection, de facto being associated with irreversible liver damage, fibrosis, and carcinogenesis. Both liver-resident cells (e.g., Kupffer cells, hepatic stellate cells, sinusoidal endothelial cells) and cells that are recruited in response to injury (e.g., monocytes, macrophages, dendritic cells, natural killer cells) emit pro-inflammatory signals including - but not limited to - cytokines, chemokines, lipid messengers, and reactive oxygen species that contribute to the apoptotic or necrotic demise of hepatocytes. In turn, dying hepatocytes release damage-associated molecular patterns that-upon binding to evolutionary conserved pattern recognition receptors-activate cells of the innate immune system to further stimulate inflammatory responses, hence establishing a highly hepatotoxic feedforward cycle of inflammation and cell death. In this review, we discuss the cellular and molecular mechanisms that account for the most deleterious effect of hepatic inflammation at the cellular level, that is, the initiation of a massive cell death response among hepatocytes.
Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5-lipoxygenase activating protein; AGER; ALOX5; ANT; ASK1; ATF6; Apoptosis; C/EPB homologous protein; CFLAR; CHOP; COX2; CRT; DAMP; DAPK1; DCC; DIABLO; ECP; EDN; EGFR; EIF2AK3; EP; ER; ERN1; FFA; FLAP; FPR1; GADD34; GM-CSF; GRP78; GSK-3β; HBV; HCV; HFD; HMGB1; HSC; HSP; IFNγ; IL; IL-1 receptor antagonist; IL-1RA; IR; IRE1α; JNK; LPS; Lipotoxicity; MAMP; MAPK; MBP; MLKL; MOMP; NADPH oxidase; NAFLD; NASH; NK; NO; NO synthase; NOS; NOX; NSAID; Necrosis; Non-alcoholic necrosis steatohepatitis; PERK; PGAM5; PGE; PGE receptor 1, subtype EP1; PINK1; PKR-related ER kinase; PP1; PRR; PTEN-induced putative kinase 1; PTGER1; PTPC; Pattern recognition receptors; RIPK1; RNS; ROS; S1P; SIGLEC10; SIRS; STAT3; TGFβ; TLR; TNF receptor 1; TNF-related apoptosis inducing ligand; TNFR1; TNFα; TRAIL; Toll-like receptor; Tumor necrosis factor receptor; UPR; VDAC; aSMase; acidic sphingomyelinase; activating transcription factor 6; adenine nucleotide translocase; advanced glycosylation end product-specific receptor; apoptosis signal-regulating kinase 1; arachidonate 5-lipoxygenase; c-Jun N-terminal kinase; calreticulin; caspase-8 and FADD-like apoptosis regulator; cyclooxygenase 2; damage-associated molecular pattern; death-associated protein kinase 1; deleted in colorectal carcinoma; direct IAP-binding protein with low pI; eIF2α; eIF2α kinase 3; eNOS; endoplasmic reticulum; endoplasmic reticulum to nucleus signaling 1; endothelial NOS; eosinophil cationic protein; eosinophil peroxidase; eosinophil-derived neurotoxin; epidermal growth factor receptor; eukaryotic translation initiation factor 2α; formyl peptide receptor 1; free fatty acid; glucose-regulated protein, 78kDa; glycogen synthase kinase 3β; granulocyte macrophage colony stimulating factor; growth arrest- and DNA damage-inducible gene 34; heat-shock protein; hepatic stellate cell; hepatitis B virus; hepatitis C virus; high mobility group box 1; high-fat diet; iNOS; inducible NOS; inositol-requiring enzyme 1α; interferon γ; interleukin; ischemia/reperfusion; lipopolysaccharide; major basic protein; microbe-associated molecular pattern; mitochondrial outer membrane permeabilization; mitochondrial transmembrane potential; mitogen-activated protein kinase; mixed lineage kinase domain-like; natural killer; nitric oxide; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; non-steroidal anti-inflammatory drug; pattern recognition receptor; permeability transition pore complex; phosphoglycerate mutase family member 5; prostaglandin E; protein phosphatase 1; reactive nitrogen species; reactive oxygen species; receptor-interacting protein kinase 1; sialic acid-binding Ig-like lectin 10; signal transducer and activator of transcription 3; sphingosine-1-phosphate; systemic inflammatory response syndrome; transforming growth factor β; tumor necrosis factor α; unfolded protein response; voltage-dependent anion channel; Δψ(m)

Mesh:

Substances:

Year:  2013        PMID: 23567086     DOI: 10.1016/j.jhep.2013.03.033

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  288 in total

1.  Diethylnitrosamine-induced cirrhosis in Wistar rats: an experimental feasibility study.

Authors:  Silvia Bona; Andrea Janz Moreira; Graziella Ramos Rodrigues; Carlos Thadeu Cerski; Themis Reverbel da Silveira; Claudio Augusto Marroni; Norma Possa Marroni
Journal:  Protoplasma       Date:  2014-11-05       Impact factor: 3.356

2.  The OPA1 Gene Mutations Are Frequent in Han Chinese Patients with Suspected Optic Neuropathy.

Authors:  A-Mei Zhang; Rui Bi; Qiu-Xiang Hu; Yu Fan; Qingjiong Zhang; Yong-Gang Yao
Journal:  Mol Neurobiol       Date:  2016-02-11       Impact factor: 5.590

3.  Sab (Sh3bp5) dependence of JNK mediated inhibition of mitochondrial respiration in palmitic acid induced hepatocyte lipotoxicity.

Authors:  Sanda Win; Tin Aung Than; Bao Han Allison Le; Carmen García-Ruiz; Jose C Fernandez-Checa; Neil Kaplowitz
Journal:  J Hepatol       Date:  2015-02-07       Impact factor: 25.083

4.  Circulating mortalin autoantibody--a new serological marker of liver cirrhosis.

Authors:  Wen-Jing Lu; Nishant Saxena; John M Luk; Sunil C Kaul; Renu Wadhwa
Journal:  Cell Stress Chaperones       Date:  2015-04-24       Impact factor: 3.667

5.  Extracellular vesicles released by hepatocytes from gastric infusion model of alcoholic liver disease contain a MicroRNA barcode that can be detected in blood.

Authors:  Akiko Eguchi; Raul G Lazaro; Jiaohong Wang; Jihoon Kim; Davide Povero; Brandon Willliams; Samuel B Ho; Peter Stärkel; Bernd Schnabl; Lucila Ohno-Machado; Hidekazu Tsukamoto; Ariel E Feldstein
Journal:  Hepatology       Date:  2016-11-10       Impact factor: 17.425

6.  Trial watch: Naked and vectored DNA-based anticancer vaccines.

Authors:  Norma Bloy; Aitziber Buqué; Fernando Aranda; Francesca Castoldi; Alexander Eggermont; Isabelle Cremer; Catherine Sautès-Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-04-02       Impact factor: 8.110

Review 7.  Trial Watch-Oncolytic viruses and cancer therapy.

Authors:  Jonathan Pol; Aitziber Buqué; Fernando Aranda; Norma Bloy; Isabelle Cremer; Alexander Eggermont; Philippe Erbs; Jitka Fucikova; Jérôme Galon; Jean-Marc Limacher; Xavier Preville; Catherine Sautès-Fridman; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-12-08       Impact factor: 8.110

Review 8.  Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy.

Authors:  Jonathan Pol; Erika Vacchelli; Fernando Aranda; Francesca Castoldi; Alexander Eggermont; Isabelle Cremer; Catherine Sautès-Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

9.  Interleukin-1β (IL-1β) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein δ (C/EBPδ) expression in hepatocytes.

Authors:  Yohei Kanamori; Masaru Murakami; Makoto Sugiyama; Osamu Hashimoto; Tohru Matsui; Masayuki Funaba
Journal:  J Biol Chem       Date:  2017-04-24       Impact factor: 5.157

10.  Liver Fatty Acid Binding Protein Deficiency Provokes Oxidative Stress, Inflammation, and Apoptosis-Mediated Hepatotoxicity Induced by Pyrazinamide in Zebrafish Larvae.

Authors:  Yun Zhang; Kechun Liu; Hozeifa M Hassan; Hongli Guo; Pingping Ding; Liwen Han; Qiuxia He; Weiyun Chen; Chung-Der Hsiao; Luyong Zhang; Zhenzhou Jiang
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.